Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pneumothorax, Chest Drain, and Commercial Air Travel.
Minotti B, Pulver C, Schaub P, Sieber R, von Ow D, Leskow P. Minotti B, et al. Among authors: schaub p. Ann Emerg Med. 2019 May;73(5):551-552. doi: 10.1016/j.annemergmed.2019.01.010. Ann Emerg Med. 2019. PMID: 31029295 No abstract available.
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P; STAR SIGN Study Investigators; Friedrich M, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: schaub p. Aliment Pharmacol Ther. 2023 Jan;57(1):103-116. doi: 10.1111/apt.17264. Epub 2022 Oct 28. Aliment Pharmacol Ther. 2023. PMID: 36307899 Free PMC article.
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P; STAR SIGN Study Investigators; Albrich WC, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: schaub p. Aliment Pharmacol Ther. 2023 Oct;58(7):678-691. doi: 10.1111/apt.17661. Epub 2023 Aug 12. Aliment Pharmacol Ther. 2023. PMID: 37571863
Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
Rabe E, Hoffmann U, Schimke A, Heinken A, Langer F, Noppeney T, Pittrow D, Klotsche J, Gerlach HE, Bauersachs R; INSIGHTS-SVT Study Collaborators. Rabe E, et al. Eur J Vasc Endovasc Surg. 2023 Nov;66(5):697-704. doi: 10.1016/j.ejvs.2023.08.031. Epub 2023 Aug 12. Eur J Vasc Endovasc Surg. 2023. PMID: 37573936 Free article.
Molecular characterization and safety assessment of biofortified provitamin A rice.
Oliva N, Florida Cueto-Reaño M, Trijatmiko KR, Samia M, Welsch R, Schaub P, Beyer P, Mackenzie D, Boncodin R, Reinke R, Slamet-Loedin I, Mallikarjuna Swamy BP. Oliva N, et al. Among authors: schaub p. Sci Rep. 2020 Jan 28;10(1):1376. doi: 10.1038/s41598-020-57669-5. Sci Rep. 2020. PMID: 31992721 Free PMC article.
48 results